Daiwa Securities Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.22M | Buy |
12,941
+35
| +0.3% | +$11.4K | 0.02% | 458 |
|
|
2025
Q1 | $3.49M | Buy |
12,906
+355
| +3% | +$95.9K | 0.01% | 470 |
|
|
2024
Q4 | $2.95M | Buy |
12,551
+479
| +4% | +$113K | 0.01% | 503 |
|
|
2024
Q3 | $3.32M | Buy |
12,072
+780
| +7% | +$215K | 0.02% | 461 |
|
|
2024
Q2 | $2.74M | Buy |
11,292
+371
| +3% | +$90.2K | 0.01% | 478 |
|
|
2024
Q1 | $1.63M | Buy |
10,921
+116
| +1% | +$17.3K | 0.01% | 604 |
|
|
2023
Q4 | $2.07M | Buy |
10,805
+400
| +4% | +$76.6K | 0.01% | 508 |
|
|
2023
Q3 | $1.84M | Sell |
10,405
-114
| -1% | -$20.2K | 0.01% | 516 |
|
|
2023
Q2 | $2M | Buy |
10,519
+71
| +0.7% | +$13.5K | 0.01% | 498 |
|
|
2023
Q1 | $2.09M | Buy |
10,448
+610
| +6% | +$122K | 0.01% | 483 |
|
|
2022
Q4 | $2.34M | Sell |
9,838
-1,430
| -13% | -$340K | 0.02% | 433 |
|
|
2022
Q3 | $2.26M | Buy |
11,268
+2,003
| +22% | +$401K | 0.02% | 427 |
|
|
2022
Q2 | $1.35M | Buy |
9,265
+312
| +3% | +$45.5K | 0.01% | 562 |
|
|
2022
Q1 | $1.46M | Buy |
8,953
+534
| +6% | +$87.2K | 0.01% | 590 |
|
|
2021
Q4 | $1.43M | Sell |
8,419
-76
| -0.9% | -$12.9K | 0.01% | 598 |
|
|
2021
Q3 | $1.6M | Buy |
8,495
+2,697
| +47% | +$509K | 0.01% | 552 |
|
|
2021
Q2 | $983K | Sell |
5,798
-2,015
| -26% | -$342K | 0.01% | 652 |
|
|
2021
Q1 | $1.1M | Buy |
7,813
+2,399
| +44% | +$339K | 0.01% | 583 |
|
|
2020
Q4 | $704K | Sell |
5,414
-436
| -7% | -$56.7K | 0.01% | 670 |
|
|
2020
Q3 | $852K | Buy |
5,850
+475
| +9% | +$69.2K | 0.01% | 549 |
|
|
2020
Q2 | $585K | Hold |
5,375
| – | – | 0.01% | 496 |
|
|
2020
Q1 | $585K | Hold |
5,375
| – | – | 0.01% | 606 |
|
|
2019
Q4 | $619K | Sell |
5,375
-79
| -1% | -$9.1K | 0.01% | 648 |
|
|
2019
Q3 | $439K | Buy |
5,454
+1,648
| +43% | +$133K | ﹤0.01% | 711 |
|
|
2019
Q2 | $276K | Hold |
3,806
| – | – | ﹤0.01% | 812 |
|
|
2019
Q1 | $356K | Buy |
3,806
+28
| +0.7% | +$2.62K | ﹤0.01% | 734 |
|
|
2018
Q4 | $275K | Buy |
3,778
+350
| +10% | +$25.5K | ﹤0.01% | 758 |
|
|
2018
Q3 | $300K | Hold |
3,428
| – | – | ﹤0.01% | 783 |
|
|
2018
Q2 | $338K | Hold |
3,428
| – | – | ﹤0.01% | 753 |
|
|
2018
Q1 | $408K | Buy |
3,428
+728
| +27% | +$86.6K | ﹤0.01% | 677 |
|
|
2017
Q4 | $343K | Buy |
+2,700
| New | +$343K | ﹤0.01% | 722 |
|
|
2016
Q4 | – | Sell |
-1,800
| Closed | -$122K | – | 1008 |
|
|
2016
Q3 | $122K | Hold |
1,800
| – | – | ﹤0.01% | 775 |
|
|
2016
Q2 | $100K | Hold |
1,800
| – | – | ﹤0.01% | 804 |
|
|
2016
Q1 | $113K | Buy |
1,800
+200
| +13% | +$12.6K | ﹤0.01% | 785 |
|
|
2015
Q4 | $151K | Hold |
1,600
| – | – | ﹤0.01% | 738 |
|
|
2015
Q3 | $129K | Buy |
1,600
+400
| +33% | +$32.3K | ﹤0.01% | 766 |
|
|
2015
Q2 | $144K | Buy |
+1,200
| New | +$144K | ﹤0.01% | 792 |
|